AI-generated summary
The authors studied breast cancer MDA-MB-231 cells treated with hypocrellin B activated by light-emitting diode (LED) light. They report that the treatment reduced cell viability in a dose-dependent manner and increased apoptosis, with early and late apoptotic rates rising to 17.46% and 32.80%. The authors describe this as a promising strategy, although the study was conducted in cultured cells.
- Who or what was studied
- MDA-MB-231 breast cancer cells grown in culture
- Limits stated in the abstract
- The study was conducted in cultured cells rather than in patients or animals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.